MI SB0630 | 2019-2020 | 100th Legislature

Michigan Senate Bill 630 (Prior Session Legislation)

Status

Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on July 22 2020 - 100% progression
Action: 2020-07-22 - Assigned Pa 0142'20 With Immediate Effect
Text: Latest bill text (Chaptered) [HTML]

Summary

Health: pharmaceuticals; wholesale distributor-broker license; create. Amends secs. 16111, 16333, 17705, 17706, 17707, 17709, 17722, 17742, 17748, 17767 & 17768 of 1978 PA 368 (MCL 333.16111 et. seq.) & adds secs. 17748e & 17748f.

Title

Roll Calls

2020-06-24 - House - House Third Reading: Given Immediate Effect Roll Call # 266 (Y: 99 N: 9 NV: 0 Abs: 0) [PASS]
2020-06-10 - House - Reported With Recommendation Without Amendment (Y: 11 N: 0 NV: 0 Abs: 0) [PASS]
2020-05-20 - Senate - Senate Third Reading: Passed Roll Call # 149 (Y: 36 N: 0 NV: 0 Abs: 2) [PASS]
2020-03-17 - Senate - Reported Favorably With Substitute S-3 (Y: 10 N: 0 NV: 0 Abs: 0) [PASS]

History

Date	Chamber	Action
2020-07-22	Senate	Assigned Pa 0142'20 With Immediate Effect
2020-07-22	Senate	Filed With Secretary Of State 07/14/2020 10:34 Am
2020-07-22	Senate	Approved By Governor 07/13/2020 01:48 Pm
2020-07-22	Senate	Presented To Governor 06/30/2020 11:03 Am
2020-06-25	Senate	Ordered Enrolled
2020-06-25	Senate	Full Title Agreed To
2020-06-25	Senate	Given Immediate Effect
2020-06-24	House	Returned To Senate
2020-06-24	House	Inserted Full Title
2020-06-24	House	Passed; Given Immediate Effect Roll Call # 266 Yeas 99 Nays 9 Excused 0 Not Voting 1
2020-06-24	House	Read A Third Time
2020-06-17	House	Placed On Third Reading
2020-06-17	House	Read A Second Time
2020-06-10	House	Referred To Second Reading
2020-06-10	House	Reported With Recommendation Without Amendment
2020-06-02	House	Referred To Committee On Ways And Means
2020-05-20	House	Referred To Committee On Health Policy
2020-05-20	House	Read A First Time
2020-05-20	House	Received On 05/20/2020
2020-05-20	Senate	Passed Roll Call # 149 Yeas 36 Nays 0 Excused 2 Not Voting 0
2020-05-19	Senate	Placed On Order Of Third Reading With Substitute (s-3)
2020-05-19	Senate	Substitute (s-3) Concurred In
2020-05-19	Senate	Reported By Committee Of The Whole Favorably With Substitute (s-3)
2020-03-17	Senate	Referred To Committee Of The Whole With Substitute (s-3)
2020-03-17	Senate	Committee Recommended Immediate Effect
2020-03-17	Senate	Reported Favorably With Substitute (s-3)
2019-10-31	Senate	Referred To Committee On Health Policy And Human Services
2019-10-31	Senate	Introduced By Senator John Bizon, M.d.

Subjects

Health: pharmaceuticals
State agencies (existing): licensing and regulatory affairs

Michigan State Sources

Type	Source
Summary	https://legislature.mi.gov/doc.aspx?2019-SB-0630
Text	https://legislature.mi.gov/documents/2019-2020/billintroduced/Senate/htm/2019-SIB-0630.htm
Text	https://legislature.mi.gov/documents/2019-2020/billengrossed/Senate/htm/2019-SEBS-0630.htm
Text	https://legislature.mi.gov/documents/2019-2020/billenrolled/Senate/htm/2019-SNB-0630.htm
Text	https://legislature.mi.gov/documents/2019-2020/publicact/htm/2020-PA-0142.htm
Roll Call	https://legislature.mi.gov/documents/2019-2020/Journal/Senate/htm/2020-SJ-03-17-029.htm
Roll Call	https://legislature.mi.gov/documents/2019-2020/Journal/Senate/htm/2020-SJ-05-20-043.htm
Roll Call	https://legislature.mi.gov/documents/2019-2020/Journal/House/htm/2020-HJ-06-10-052.htm
Roll Call	https://legislature.mi.gov/documents/2019-2020/Journal/House/htm/2020-HJ-06-24-058.htm